CDMO Services

Arranta Bio is focused on providing process development and cGMP manufacturing services for live biotherapeutic products (LBPs) targeting diseases linked to the human microbiome.

With a range of platform technologies, we are executing our business plan to rapidly grow infrastructure and capabilities to meet the needs of innovator companies in this exciting area.

Building on the foundation of Captozyme, our team brings 10 years of experience developing processes for LBPs at our cGMP facility in Gainesville, Florida, where we offer process development and early clinical supply. We are also establishing a larger cGMP facility in Watertown, Massachusetts that will provide late-stage clinical and commercial supply.

Development Services

Media Formulation
Formulation
Cell Banking
Lyophilization
Fermentation
Drug Product Finishing
Cell Harvest & Downstream Process
Analytical Services

cGMP Services

Cell Banking (MCB, WCB)
Primary Packaging
Frozen Blend
Media Production
Drug Substance
• Fermentation
• Filtration / Downstream
Drug Product
• Lyophilization
• Encapsulation

Arranta Bio’s Facilities

Our cGMP facility in Gainesville, Florida brings 10 years of experience in the development and supply of LBPs, and we are working on bringing online our commercial-ready facility in Watertown, Massachusetts.

1 Gainesville, FL

Process Development
Early Clinical Supply

LPBs

Obligate
Facultative
Microareophilic

Clean Room

ISO 8 Fermentation Room
ISO 8 Blending Room
ISO 7 Lyophilization Suites

Compliance

FDA Code of Federal Regulations (Part 21)
European Advanced Therapy Medicinal Products (ATMP)

2 Watertown, MA

Late-stage Clinical Supply
Commercial Supply

Commercial-Ready Facility Planned

Large-scale cGMP manufacturing
State-of-the-art equipment & processes
Scale-up to late-stage clinical supply and commercialization